派林生物：公司控制权转让事项正在推进法律法规要求的批准程序

Core Viewpoint - The company is progressing smoothly with the approval procedures required for the transfer of control, and investors are encouraged to pay attention to future announcements regarding this matter [2] Group 1 - The company responded to investor inquiries on November 7 regarding the status of its control transfer [2] - The transfer of control is currently advancing through the necessary legal and regulatory approval processes [2] - The company indicates that the progress of the control transfer is going well [2]